Cargando…
What does equitable global health research and delivery look like? Tackling Infections to Benefit Africa (TIBA) partnership as a case study
There is a current global push to identify and implement best practice for delivering maximum impact from development research in low-income and middle-income countries. Here, we describe a model of research and capacity building that challenges traditional approaches taken by western funders in Afr...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040064/ https://www.ncbi.nlm.nih.gov/pubmed/36963785 http://dx.doi.org/10.1136/bmjgh-2022-011028 |
_version_ | 1784912402251251712 |
---|---|
author | Mutapi, Francisca Banda, Geoffrey Woolhouse, Mark |
author_facet | Mutapi, Francisca Banda, Geoffrey Woolhouse, Mark |
author_sort | Mutapi, Francisca |
collection | PubMed |
description | There is a current global push to identify and implement best practice for delivering maximum impact from development research in low-income and middle-income countries. Here, we describe a model of research and capacity building that challenges traditional approaches taken by western funders in Africa. Tackling Infections to Benefit Africa (TIBA) is a global health research and delivery partnership with a focus on strengthening health systems to combat neglected tropical diseases, malaria and emerging pathogens in Africa. Partners are academic and research institutions based in Ghana, Sudan, Rwanda, Uganda, Kenya, Tanzania, Zimbabwe, Botswana, South Africa and the UK. Fifteen other African countries have participated in TIBA activities. With a starting budget of under £7 million, and in just 4 years, TIBA has had a verified impact on knowledge, policy practice and capacity building, and on national and international COVID-19 responses in multiple African countries. TIBA’s impact is shown in context-specific metrics including: strengthening the evidence base underpinning international policy on neglected tropical diseases; 77% of research publications having Africa-based first and/or last authors; postgraduate, postdoctoral and professional training; career progression for African researchers and health professionals with no net brain drain from participating countries; and supporting African institutions. Training in real-time SARS-CoV-2 viral genome sequencing provided new national capabilities and capacities that contributed to both national responses and global health security through variant detection and tracking. TIBA’s experience confirms that health research for Africa thrives when the agenda and priorities are set in Africa, by Africans, and the work is done in Africa. Here, we share 10 actionable recommendations for researchers and funders from our lessons learnt. |
format | Online Article Text |
id | pubmed-10040064 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-100400642023-03-27 What does equitable global health research and delivery look like? Tackling Infections to Benefit Africa (TIBA) partnership as a case study Mutapi, Francisca Banda, Geoffrey Woolhouse, Mark BMJ Glob Health Practice There is a current global push to identify and implement best practice for delivering maximum impact from development research in low-income and middle-income countries. Here, we describe a model of research and capacity building that challenges traditional approaches taken by western funders in Africa. Tackling Infections to Benefit Africa (TIBA) is a global health research and delivery partnership with a focus on strengthening health systems to combat neglected tropical diseases, malaria and emerging pathogens in Africa. Partners are academic and research institutions based in Ghana, Sudan, Rwanda, Uganda, Kenya, Tanzania, Zimbabwe, Botswana, South Africa and the UK. Fifteen other African countries have participated in TIBA activities. With a starting budget of under £7 million, and in just 4 years, TIBA has had a verified impact on knowledge, policy practice and capacity building, and on national and international COVID-19 responses in multiple African countries. TIBA’s impact is shown in context-specific metrics including: strengthening the evidence base underpinning international policy on neglected tropical diseases; 77% of research publications having Africa-based first and/or last authors; postgraduate, postdoctoral and professional training; career progression for African researchers and health professionals with no net brain drain from participating countries; and supporting African institutions. Training in real-time SARS-CoV-2 viral genome sequencing provided new national capabilities and capacities that contributed to both national responses and global health security through variant detection and tracking. TIBA’s experience confirms that health research for Africa thrives when the agenda and priorities are set in Africa, by Africans, and the work is done in Africa. Here, we share 10 actionable recommendations for researchers and funders from our lessons learnt. BMJ Publishing Group 2023-03-24 /pmc/articles/PMC10040064/ /pubmed/36963785 http://dx.doi.org/10.1136/bmjgh-2022-011028 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Practice Mutapi, Francisca Banda, Geoffrey Woolhouse, Mark What does equitable global health research and delivery look like? Tackling Infections to Benefit Africa (TIBA) partnership as a case study |
title | What does equitable global health research and delivery look like? Tackling Infections to Benefit Africa (TIBA) partnership as a case study |
title_full | What does equitable global health research and delivery look like? Tackling Infections to Benefit Africa (TIBA) partnership as a case study |
title_fullStr | What does equitable global health research and delivery look like? Tackling Infections to Benefit Africa (TIBA) partnership as a case study |
title_full_unstemmed | What does equitable global health research and delivery look like? Tackling Infections to Benefit Africa (TIBA) partnership as a case study |
title_short | What does equitable global health research and delivery look like? Tackling Infections to Benefit Africa (TIBA) partnership as a case study |
title_sort | what does equitable global health research and delivery look like? tackling infections to benefit africa (tiba) partnership as a case study |
topic | Practice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040064/ https://www.ncbi.nlm.nih.gov/pubmed/36963785 http://dx.doi.org/10.1136/bmjgh-2022-011028 |
work_keys_str_mv | AT mutapifrancisca whatdoesequitableglobalhealthresearchanddeliverylookliketacklinginfectionstobenefitafricatibapartnershipasacasestudy AT bandageoffrey whatdoesequitableglobalhealthresearchanddeliverylookliketacklinginfectionstobenefitafricatibapartnershipasacasestudy AT woolhousemark whatdoesequitableglobalhealthresearchanddeliverylookliketacklinginfectionstobenefitafricatibapartnershipasacasestudy |